Few QuestionsFirst of all, I should say that I am disappointed at the significant drop in Covid testing revenues, especially since Stage added Rexall as a distributor of the test kits. Would have thought it would be at least $1m.
That said, I am still hopefully that the incoming members of the board, and the new CFO/COO will bring some much needed energy, strategy and goal execution for StageZero.
What I want to see StageZero follow through on with frequent NRs releases, relate to the following:
1. Completion of Care acquisition.
2. Announcement of first AVRT/Aristotle revenues.
3. Announcement of new partnerships that are currently not part of Care/HC.
4. Announcement of ANY buy-out offers, regardless of whether the CEO thinks the offer is too low.
5. Success stories of partnerships they converted from Covid testing to AVRT/Aristotle testing.
I can add more, like "is SEEK going to be an active partnership?", but sadly am too lazy to type right now.
https://seekacure.com/
Cheers!